Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies. (Q34330617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Riad Salem

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Khairuddin Memon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Robert J Lewandowski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

Current Treatment Options in Oncology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

403-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22773276%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11864-012-0200-x

7 February 2020

exact match

0 references

cites work

Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Actual 10-year survival after resection of colorectal liver metastases defines cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Surgical treatment of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Angiographic considerations in patients undergoing liver-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radioembolization with 90Y microspheres: angiographic and technical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Technical aspects of radioembolization with 90Y microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Embolotherapy: agents, clinical applications, and techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Regression of Ocular Melanoma Metastatic to the Liver After Hepatic Arterial Chemoembolization With Cisplatin and Polyvinyl Sponge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Arteritis following intra-arterial chemotherapy for liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Liver disease induced by radioembolization of liver tumors: description and possible risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Gastroduodenal injury after radioembolization of hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0200-X

Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy

21 January 2018

1 reference

12 December 2020

Yttrium-90 microspheres: radiation therapy for unresectable liver cancer

1 reference

12 December 2020

Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial

1 reference

12 December 2020

Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging

1 reference

12 December 2020

Chemoembolization of hepatic malignancies

1 reference

12 December 2020

Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma

1 reference

12 December 2020

Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience

1 reference

12 December 2020

Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging

1 reference

12 December 2020

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes

1 reference

12 December 2020

Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.

1 reference

12 December 2020

1 reference

12 December 2020

Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer

1 reference

12 December 2020

The blood supply of neoplasms in the liver

1 reference

12 December 2020

Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients

1 reference

12 December 2020

Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin

1 reference

12 December 2020

Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study

1 reference

12 December 2020

Chemoembolization of liver metastasis from breast carcinoma

1 reference

12 December 2020

Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population

1 reference

12 December 2020

Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry.

1 reference

12 December 2020

Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol

1 reference

12 December 2020